RT Journal Article SR Electronic T1 Aspirin for primary prevention of atherosclerotic cardiovascular events JF Cleveland Clinic Journal of Medicine JO Cleve Clin J Med FD Cleveland Clinic SP 300 OP 311 DO 10.3949/ccjm.87a.19045 VO 87 IS 5 A1 Schenone, Aldo L. A1 Lincoff, A. Michael YR 2020 UL http://www.ccjm.org/content/87/5/300.abstract AB Recent trials evaluated the impact of aspirin for primary prevention of cardiovascular events in patients at intermediate risk, patients with diabetes, and the elderly, and the results have been incorporated into the most recent professional guidelines. For the most part, the role of aspirin in primary prevention remains limited, albeit not adequately tested in those at higher risk.